Last reviewed · How we verify

NCT05893316

UroCAD for Hematuria Evaluation--A Prospective, Multi-center Study

Status unknown Last updated 7 June 2023
What this trial tests

trial testing urine sample collection in Hematuria in 1,000 participants. Status unknown.

Timeline
1 June 2023
Primary endpoint
31 December 2023
1 February 2024

Quick facts

Lead sponsorChanghai Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date1 June 2023
Primary completion31 December 2023
Estimated completion1 February 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Changhai Hospital

Who can join

18 and older, any sex, with Hematuria or Urothelial Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hematuria is recognized as an important sigh of potential urinary tract malignancy. Therefore, understanding the disease processes and discovering the potential urothelial carcinoma (UC) underlying this important sign is critical. Cystoscopy, urine cytology and imaging are most reliable methods for UC diagnosis, but certain drawbacks exist for these methods, such as invasiveness or inaccuracy. Chromosomal instability (CIN) is a hallmark of human cancer, and it's related with tumor stage and grade. Previous research has proved that analyzing CIN of the DNA extracted from urothelial cells in urine samples seems a promising method for detecting UC. Here we intend to assess CIN's performance for hematuria evaluation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of urine sample collection

Trials testing the same drug.

Other recruiting trials for Hematuria

Currently open trials in the same condition.

Other Changhai Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05893316.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing